These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6965535

  • 21. Adenosine deaminase positive, E receptor negative lymphoma.
    Gordon EM, Gross S, Altman A.
    Am J Pediatr Hematol Oncol; 1982; 4(2):135-9. PubMed ID: 6981356
    [Abstract] [Full Text] [Related]

  • 22. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
    Tsartsidze E, Betaneli M.
    Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
    [Abstract] [Full Text] [Related]

  • 23. [Histopathological features of T- and B-cell lymphomas. The old terms corresponding with those of the new classification (LSG classification) for non-Hodgkin's lymphoma (author's transl)].
    Tajama K, Suchi T.
    Rinsho Byori; 1980 Aug; 28(8):724-32. PubMed ID: 6970829
    [No Abstract] [Full Text] [Related]

  • 24. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH.
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [Abstract] [Full Text] [Related]

  • 25. [Acid phosphatase and beta-glucuronidase activities of T and B lymphocytes in patients with pulmonary tuberculosis (author's transl)].
    Aoki H, Takada K, Sugiura T, Morishita M, Torii Y, Ichimura K, Ina Y, Yamamoto M, Isoe K, Inoue T.
    Kekkaku; 1981 Jul; 56(7):347-54. PubMed ID: 6977068
    [No Abstract] [Full Text] [Related]

  • 26. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P, van der Voort R, Koopman G, Dragosics B, van Krieken JH, Kluin P, Meenan J, Lazarovits AI, Radaszkiewicz T, Pals ST.
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [Abstract] [Full Text] [Related]

  • 27. [Malignant lymphomas and sarcoidosis (author's transl)].
    Casassus P, Vannetzel JM, Experton B, Valeyre D, Brun B, Teillet F, Turpin F, Lortholary P, Battesti JP.
    Nouv Presse Med; 1982 Jul 03; 11(31):2339-42. PubMed ID: 6213932
    [Abstract] [Full Text] [Related]

  • 28. Non-Hodgkin's lymphomas: contemporary classification and correlates.
    Howard DR, Batsakis JG.
    Ann Otol Rhinol Laryngol; 1985 Jul 03; 94(3):326-8. PubMed ID: 3874578
    [Abstract] [Full Text] [Related]

  • 29. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders.
    Tbakhi A, Edinger M, Myles J, Pohlman B, Tubbs RR.
    Cytometry; 1996 Oct 01; 25(2):113-24. PubMed ID: 8891441
    [Abstract] [Full Text] [Related]

  • 30. [Surface markers of the lymphoid cells in non-Hodgkin's lymphoma].
    Płuzańska A, Polkowska-Kulesza E, Robak T, Kuźmicka J, Mazurowa A, Szadowska A, Woźniak L.
    Acta Haematol Pol; 1980 Oct 01; 11(1):31-9. PubMed ID: 6966115
    [No Abstract] [Full Text] [Related]

  • 31. [Pathologicoanatomical characteristics of the most important forms of non-Hodgkin malignant lymphomas (based on the Kiel classification)].
    Shtern RD.
    Arkh Patol; 1980 Oct 01; 42(11):71-80. PubMed ID: 7004413
    [Abstract] [Full Text] [Related]

  • 32. Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin.
    Geerts ML, Burg G, Schmoeckel C, Braun-Falco O.
    J Dermatol Surg Oncol; 1984 Apr 01; 10(4):306-12. PubMed ID: 6608543
    [Abstract] [Full Text] [Related]

  • 33. [Histochemical comparison of the enzyme profiles of healthy veins and varicose veins].
    Haardt B.
    Phlebologie; 1986 Apr 01; 39(4):921-31. PubMed ID: 3562564
    [Abstract] [Full Text] [Related]

  • 34. [Differentiation of non-Hodgkin's lymphoma: immunological, cell-kinetic, and physical methods (author's transl)].
    Huber Ch, Michlmayr G, Huber H, Braunsteiner H.
    Dtsch Med Wochenschr; 1977 Dec 09; 102(49):1795-9. PubMed ID: 590104
    [Abstract] [Full Text] [Related]

  • 35. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
    Lai R, Arber DA, Chang KL, Wilson CS, Weiss LM.
    Mod Pathol; 1998 Sep 09; 11(9):864-9. PubMed ID: 9758366
    [Abstract] [Full Text] [Related]

  • 36. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E, Burchardt K.
    Z Gesamte Inn Med; 1981 Sep 15; 36(18):681-2. PubMed ID: 6976047
    [No Abstract] [Full Text] [Related]

  • 37. Introduction--functional and morphological aspects of malignant lymphomas.
    Lennert K.
    Adv Exp Med Biol; 1979 Sep 15; 114():541-3. PubMed ID: 380301
    [No Abstract] [Full Text] [Related]

  • 38. [A cytochemical study of T, active T, non active T and B lymphocytes in respect to acid phosphatase and beta-glucuronidase activity (author's transl)].
    Takada K, Shibata H, Yamamoto M.
    Rinsho Byori; 1981 Feb 15; 29(2):183-6. PubMed ID: 6971950
    [No Abstract] [Full Text] [Related]

  • 39. [Immunological and immunochemical methods and their application in the classification of malignant non-Hodgkin's-lymphoma (author's transl)].
    Stein H.
    Verh Dtsch Ges Pathol; 1975 Feb 15; 59():510-22. PubMed ID: 766467
    [No Abstract] [Full Text] [Related]

  • 40. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM, Shahsafaei A.
    Mod Pathol; 1996 Oct 15; 9(10):959-65. PubMed ID: 8902831
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.